Ludhiana: IOL Chemicals and Pharmaceuticals Limited (IOL), a manufacturer of pharmaceutical (APIs) and specialty chemicals, has announced receiving EDQM
certification to supply Pantoprazole Sodium Sesquihydrate API across European market.
Pantoprazole Sodium Sesquihydrate are proton pump inhibitors used in drugs to suppress gastric acid secretion.
The company started production of Pantoprazole Sodium Sesquihydrate in Q3 FY 2020 at its
Punjab based facility.
Read also: USFDA gives its nod to IOL chemicals and pharmaceuticals for a plant in Punjab
With this CEP certification, the Company will now be able to export it
to entire Europe. IOL currently, has a total capacity of producing 240 TPA of Pantoprazole
Sodium Sesquihydrate.
Read also: IOL Chemicals and Pharmaceuticals begins commercial production of Paracetamol
Clopidogrel, Lamotrigine, Pantoprazole, Paracetamol and specialty chemicals such as Ethyl
Acetate, Iso Butyl Benzene, Mono Chloro Acetic Acid and Acetyl Chloride. The Company has DSIR
approved R&D which is fully equipped to validate existing processes.
with Zero Liquid Discharge (ZLD) system along with 17 MW captive Co-Generation plant for
self -reliance. The Company is ISO 9001:2015, 14001:2015 and BS OHSAS 18001:2007
certified.
IOL’s overseas customers are spread out across several countries including UK, Belgium,
Hungry, Spain, Germany, Italy, Netherlands, Switzerland, Poland, Ireland, USA, Peru, Brazil,
Argentina, Colombia, Indonesia, South Korea, Thailand, Bangladesh, Turkey, U.A.E., China,
Hong Kong, Egypt etc. Products are sold primarily to Branded Generic formulators both in
India & Overseas.